One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
A serum-free medium especially developed for efficient large-scale culture of LMH cells
SF501 medium is an innovative serum-free medium developed independently by Shanghai BioEngine Sci-Tech Co., Ltd., which is serum-free, protein-free, and animal-derived component-free. It is the first medium for serum-free total suspension culture of LMH cells in China. It supports efficient acclimation of adherent LMH cells and high-density growth of suspension cells and provides a high-quality environment for efficient expression of avian adenovirus vaccines. SF501 is your ideal choice for large-scale industrial suspension culture of LMH cells: the suspension culture system provides you with a significant increase in production efficiency, while the serum-free culture system provides you with maximum process stability. Currently, it has been applied on a large scale in a number of avian adenovirus vaccine production projects.
Features
Serum-free
Animal-derived component-free
Protein-free
Support the suspension adaption of LMH cells
Support the high cell-density culture of LMH cells
Support high-efficiency amplification of avian adenovirus
Advantages
The first medium in China for industrial application of avian adenovirus production based on serum-free suspension culture of LMH cells;
Full traceability by EU-certified ISO13485:2016 Quality Management System;
Excellent inter-batch consistency (CPK*>1.33);
Optional powder media for use in large-scale manufacturing with easy preparation procedures;
Powder media capable of a single batch size of 100,000 L.
*CPK: Process Capability Index. CPK>1.33 indicates good process control and small inter-batch difference of products.
Audited Supplier
Pharma Sources Insight January 2025
